REFERENCES
1. Chung BHY, Chau JFT, Wong GK. Rare versus common diseases: a false dichotomy in precision medicine. NPJ Genom Med 2021;6:19.
3. Stark Z, Schofield D, Martyn M, et al. Does genomic sequencing early in the diagnostic trajectory make a difference? Genet Med 2019;21:173-80.
4. Wise AL, Manolio TA, Mensah GA, et al. Genomic medicine for undiagnosed diseases. Lancet 2019;394:533-40.
6. Wheway G, Mitchison HM, Ambrose JC, et al. Opportunities and challenges for molecular understanding of ciliopathies - the 100,000 genomes project. Front Genet 2019;10:127.
7. Swanson CL, Kumar A, Maharaj JM, et al. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis. Gynecol Oncol 2018;149:121-6.
8. Dragojlovic N, Borle K, Kopac N, et al. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Gene Med 2020;22:1437-49.
9. Armel SR, Volenik A, Demsky R, Malcolmson J, Maganti M, McCuaig J. Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing. Gynecol Oncol 2020;158:440-5.
10. Chiang J, Ngeow J. The management of BRCA1 and BRCA2 carriers in Singapore. Chin Clin Oncol 2020;9:62.
11. Shaw T, Ishak D, Lie D, et al. The influence of Malay cultural beliefs on breast cancer screening and genetic testing: a focus group study. Psychooncology 2018;27:2855-61.
12. Steering Committee of Genomic Medicine, Hong Kong Special Administrative Region. Strategic development of genomic medicine in Hong Kong; 2020. Available from: https://www.fhb.gov.hk/download/press_and_publications/otherinfo/200300_genomic/SCGM_report_en.pdf [Last accessed on 9 Jun 2022].
13. Zhao X, Wang P, Tao X, Zhong N. Genetic services and testing in China. J Community Genet 2013;4:379-90.
14. Hegarty J, Egan SM, Jones MM, et al. The unmet need in cancer genetic services: conducting an environmental scan of the cancer genetics services in an Irish context underpinned by a mixed methods approach- report prepared for the Irish cancer society, Ireland. 2021. Available from: https://www.cancer.ie/sites/default/files/2021-04/Conducting%20an%20environmental%20scan%20of%20the%20cancer%20genetics%20services%20Report%202021.pdf [Last accessed on 9 Jun 2022].
15. Truong TK, Kenneson A, Rosen AR, Singh RH. Genetic referral patterns and responses to clinical scenarios: a survey of primary care providers and clinical geneticists. J Prim Care Community Health 2021;12:21501327211046734.
16. Yu MWC, Fung JLF, Ng APP, et al. Preparing genomic revolution: attitudes, clinical practice, and training needs in delivering genetic counseling in primary care in Hong Kong and Shenzhen, China. Mol Genet Genomic Med 2021;9:e1702.
17. Hospital Authority, Hong Kong Special Administrative Region. Strategic service framework for genetic and genomic services; 2019. Available from: https://www.ha.org.hk/haho/ho/ap/HAGGSSSF_Eng.pdf [Last accessed on 9 Jun 2022].
18. Census and Statistics Department, Hong Kong Special Administrative Region. Thematic Household Survey Report No. 74.; 2021. Available from: https://www.censtatd.gov.hk/en/data/stat_report/product/C0000022/att/B11302742021XXXXB0100.pdf [Last accessed on 9 Jun 2022].
19. Chung CCY, Chan KYK, Hui PW, et al. Cost-effectiveness analysis of chromosomal microarray as a primary test for prenatal diagnosis in Hong Kong. BMC Pregnancy Childbirth 2020;20:109.
20. Chu A, Man-Sik Tse D, To Ki Suen D, Kwong A. Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females. J Commun Gene 2021.
21. Census and Statistics Department, Hong Kong Special Administrative Region. Hong Kong Population Projections: 2020-2069; 2020. Available from: https://www.censtatd.gov.hk/en/data/stat_report/product/B1120015/att/B1120015082020XXXXB0100.pdf [Last accessed on 9 Jun 2022].
22. Census and Statistics Department, Hong Kong Special Administrative Region. 2016 population by-census: summary results; 2017. Available from: https://www.bycensus2016.gov.hk/data/16bc-summary-results.pdf [Last accessed on 9 Jun 2022].
23. Dheensa S, Samuel G, Lucassen AM, Farsides B. Towards a national genomics medicine service: the challenges facing clinical-research hybrid practices and the case of the 100 000 genomes project. J Med Ethics 2018;44:397-403.
24. Consent Clauses for Genomic Research. Consent clauses for genomic research. 2020. Available from: https://drive.google.com/file/d/1O5Ti7g7QJqS3h0ABm-LyTe02Gtq8wlKM/view [Last accessed on 9 Jun 2022].
25. Global Alliance for Genomics and Health. Global Alliance for genomics and health: consent policy (v2.0); 2019. Available from: https://www.ga4gh.org/wp-content/uploads/GA4GH-Final-Revised-Consent-Policy_16Sept2019.pdf [Last accessed on 9 Jun 2022].
27. Genomics England. Consent in the 100,000 genomes project. Available from: https://www.genomicsengland.co.uk/about-genomics-england/the-100000-genomes-project/information-for-gmc-staff/consent/ [Last accessed on 9 Jun 2022].
28. Rego S, Grove ME, Cho MK, Ormond KE. Informed consent in the genomics era. Cold Spring Harb Perspect Med 2020;10:a036582.
29. Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet 2008;83:610-5.
